Outcomes of Hypofractional Tomotherapy in Patients with Stage III Nonsmall Cell Lung Cancer Who Are Not Eligible for Surgery or Concurrent Chemoradiation

Figure 2

Overall survival (OS) rate and progression-free survival (PFS) rate in the two groups. (a) OS curves. (b) PFS curves.

(a)

(b)